These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26130494)

  • 1. False discovery rate control is not always a replacement for Bonferroni adjustment (Letter commenting on: J Clin Epidemiol. 2014;67:850-7).
    Frane AV
    J Clin Epidemiol; 2016 Jan; 69():263. PubMed ID: 26130494
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to letter by Frane: "False discovery rate control is not always a replacement for Bonferroni-type adjustment".
    Glickman ME; Rao SR; Schultz MR
    J Clin Epidemiol; 2016 Jan; 69():264. PubMed ID: 26139437
    [No Abstract]   [Full Text] [Related]  

  • 3. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies.
    Glickman ME; Rao SR; Schultz MR
    J Clin Epidemiol; 2014 Aug; 67(8):850-7. PubMed ID: 24831050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum to: Letter to the Editor: The ongoing tyranny of statistical significance testing in biomedical research.
    VanderWeele TJ
    Eur J Epidemiol; 2010 Dec; 25(12):899-900. PubMed ID: 21190126
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview of Common Statistical Tests and their Assumptions.
    Turner DP; Deng H
    Headache; 2020 May; 60(5):826-832. PubMed ID: 32337724
    [No Abstract]   [Full Text] [Related]  

  • 6. Plea for Standardized Reporting and Justification of Propensity Score Methods.
    Roth JA; Juchler F; Widmer AF; Battegay M
    Clin Infect Dis; 2019 Feb; 68(4):710-711. PubMed ID: 30137235
    [No Abstract]   [Full Text] [Related]  

  • 7. Statistics Commentary Series. Commentary No. 37: Chi-squared and its Discontents.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(1):3-5. PubMed ID: 31842043
    [No Abstract]   [Full Text] [Related]  

  • 8. Why do you need a biostatistician?
    Zapf A; Rauch G; Kieser M
    BMC Med Res Methodol; 2020 Feb; 20(1):23. PubMed ID: 32024478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pragmatic statistical issues in biological research: Introduction to special series.
    Danziger RS; Berbaum ML
    J Mol Cell Cardiol; 2019 Aug; 133():211-213. PubMed ID: 29588139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unit of analysis issues in laboratory-based research.
    Parsons NR; Teare MD; Sitch AJ
    Elife; 2018 Jan; 7():. PubMed ID: 29319501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the Editor on Cohen et al. (Letter commenting on: J Clin Epidemiol. 2015;68:299-306).
    Hoaglin DC
    J Clin Epidemiol; 2016 Jan; 69():261-2. PubMed ID: 26142918
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: The ongoing tyranny of statistical significance testing in biomedical research.
    Vanderweele TJ
    Eur J Epidemiol; 2010 Nov; 25(11):843; author reply 844-5. PubMed ID: 21103912
    [No Abstract]   [Full Text] [Related]  

  • 13. Developing a Hypothesis and Statistical Planning.
    Nizamuddin SL; Nizamuddin J; Mueller A; Ramakrishna H; Shahul SS
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1878-1882. PubMed ID: 28778775
    [No Abstract]   [Full Text] [Related]  

  • 14. Biostatistics: a toolkit for exploration, validation, and interpretation of clinical data.
    Mandrekar JN; Mandrekar SJ
    J Thorac Oncol; 2009 Dec; 4(12):1447-9. PubMed ID: 20009908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic statistics note 8: missing data--exploring the unknown.
    Bunce C; Quartilho A; Freemantle N; Doré CJ;
    Br J Ophthalmol; 2016 Mar; 100(3):291-4. PubMed ID: 26719490
    [No Abstract]   [Full Text] [Related]  

  • 16. Is It Time to Ban the P Value?
    Kraemer HC
    JAMA Psychiatry; 2019 Dec; 76(12):1219-1220. PubMed ID: 31389991
    [No Abstract]   [Full Text] [Related]  

  • 17. Instrumental variables estimation under a structural Cox model.
    Martinussen T; Nørbo Sørensen D; Vansteelandt S
    Biostatistics; 2019 Jan; 20(1):65-79. PubMed ID: 29165631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the effect size and its measures.
    Ialongo C
    Biochem Med (Zagreb); 2016; 26(2):150-63. PubMed ID: 27346958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical perspectives: all together NOT.
    Hopkins WG; Batterham AM; Impellizzeri FM; Pyne DB; Rowlands DS
    J Physiol; 2011 Nov; 589(Pt 21):5327-9; author reply 5331-2. PubMed ID: 22042548
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to the Editor referring to the article 'Testing agreement between a new method and the gold standard -How do we test?' published in Journal of Biomechanics (volume 46, Issue 16, Pages 2757-2760).
    Heinrich D
    J Biomech; 2014 Dec; 47(16):3909-10. PubMed ID: 25468665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.